219 related articles for article (PubMed ID: 12932605)
1. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).
Domanski M; Norman J; Pitt B; Haigney M; Hanlon S; Peyster E;
J Am Coll Cardiol; 2003 Aug; 42(4):705-8. PubMed ID: 12932605
[TBL] [Abstract][Full Text] [Related]
2. Diuretic use, progressive heart failure, and death in patients in SOLVD.
Ghali JK
J Am Coll Cardiol; 2004 May; 43(9):1723; author reply 1723. PubMed ID: 15120837
[No Abstract] [Full Text] [Related]
3. Diuretic use, progressive heart failure, and death in patients in the DIG study.
Domanski M; Tian X; Haigney M; Pitt B
J Card Fail; 2006 Jun; 12(5):327-32. PubMed ID: 16762792
[TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction.
Dries DL; Exner DV; Gersh BJ; Domanski MJ; Waclawiw MA; Stevenson LW
J Am Coll Cardiol; 1998 Sep; 32(3):695-703. PubMed ID: 9741514
[TBL] [Abstract][Full Text] [Related]
5. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
Knight EL; Glynn RJ; McIntyre KM; Mogun H; Avorn J
Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
[TBL] [Abstract][Full Text] [Related]
6. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction.
Cooper HA; Dries DL; Davis CE; Shen YL; Domanski MJ
Circulation; 1999 Sep; 100(12):1311-5. PubMed ID: 10491376
[TBL] [Abstract][Full Text] [Related]
7. ACE inhibitors in heart failure: what more do we need to know?
Demers C; Mody A; Teo KK; McKelvie RS
Am J Cardiovasc Drugs; 2005; 5(6):351-9. PubMed ID: 16259523
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying increased mortality risk in patients with heart failure and reduced ejection fraction randomly assigned to adaptive servoventilation in the SERVE-HF study: results of a secondary multistate modelling analysis.
Eulenburg C; Wegscheider K; Woehrle H; Angermann C; d'Ortho MP; Erdmann E; Levy P; Simonds AK; Somers VK; Zannad F; Teschler H; Cowie MR
Lancet Respir Med; 2016 Nov; 4(11):873-881. PubMed ID: 27592224
[TBL] [Abstract][Full Text] [Related]
9. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
[TBL] [Abstract][Full Text] [Related]
10. Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure.
Böhm M; Pogue J; Kindermann I; Pöss J; Koon T; Yusuf S
Eur J Heart Fail; 2014 Mar; 16(3):325-33. PubMed ID: 24464788
[TBL] [Abstract][Full Text] [Related]
11. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.
Dries DL; Exner DV; Domanski MJ; Greenberg B; Stevenson LW
J Am Coll Cardiol; 2000 Mar; 35(3):681-9. PubMed ID: 10716471
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial.
Al-Khadra AS; Salem DN; Rand WM; Udelson JE; Smith JJ; Konstam MA
J Am Coll Cardiol; 1998 Feb; 31(2):419-25. PubMed ID: 9462588
[TBL] [Abstract][Full Text] [Related]
13. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJ; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K;
Circulation; 2004 Oct; 110(17):2618-26. PubMed ID: 15492298
[TBL] [Abstract][Full Text] [Related]
14. Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee.
Butler J; Ezekowitz JA; Collins SP; Givertz MM; Teerlink JR; Walsh MN; Albert NM; Westlake Canary CA; Carson PE; Colvin-Adams M; Fang JC; Hernandez AF; Hershberger RE; Katz SD; Rogers JG; Spertus JA; Stevenson WG; Sweitzer NK; Tang WH; Stough WG; Starling RC
J Card Fail; 2012 Apr; 18(4):265-81. PubMed ID: 22464767
[TBL] [Abstract][Full Text] [Related]
15. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD).
Hamaguchi S; Kinugawa S; Tsuchihashi-Makaya M; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
Circ J; 2012; 76(8):1920-7. PubMed ID: 22665070
[TBL] [Abstract][Full Text] [Related]
16. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
[TBL] [Abstract][Full Text] [Related]
17. Changes in Drug Utilization and Outcome With Cardiac Resynchronization Therapy: A MADIT-CRT Substudy.
Penn J; Goldenberg I; McNitt S; Polonsky B; Ruwald MH; Zareba W; Moss AJ; Alexis JD
J Card Fail; 2015 Jul; 21(7):541-7. PubMed ID: 25800548
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
Santos AB; Roca GQ; Claggett B; Sweitzer NK; Shah SJ; Anand IS; Fang JC; Zile MR; Pitt B; Solomon SD; Shah AM
Circ Heart Fail; 2016 Apr; 9(4):e002763. PubMed ID: 27056882
[TBL] [Abstract][Full Text] [Related]
20. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.
Leyva F; Zegard A; Qiu T; Acquaye E; Ferrante G; Walton J; Marshall H
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
